ACTRN12609000716268已完成未知
Effect of intracameral Bevacizumab injection on corneal endothelial cells in patients with iris neovascularization: an in vivo evaluation
Cairo University Hospital0 个研究点目标入组 20 人开始时间: 2009年8月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 38 Years 至 60 Years（—）
- 性别
- All
入选标准
- •patients with iris neovascularization
排除标准
- •corneal edema or preoperative corneal endothelial desnity<1500 cells/mm2
研究者
相似试验
已完成
2 期
The effect of Bevacizumab on recurrent pterygiaPterygiumpterygium.IRCT201010054856N1Vice Chancellor for research, Baqiyatallah University of Medical Science20
已完成
3 期
Effect of diclofenac eye drop and Bevacizumab and Triamcinolone in preventing part of the retina edemaDiabetic retinopathyDiabetic retinopathy.IRCT2017050833875N1Vice chancellor For Research Of Ahvaz Jundishapur University of Medical Sciences45
已完成
不适用
Evaluate the effect of intravitreal Bevacizumab injection for ocular proliferative diseaseschoroidal neovascularization,proliferative diabetic retinopathy, central retinal vein occlusion neovascular glaucomaJPRN-UMIN000020467agasaki University Hospital90
招募中
4 期
Efficacy of bevacizumab by intravitreal route in choroidal neovascular membrane of eye.CTRI/2016/09/007288Govt medical college and sir takhtsinhji hospital bhavnagr30
尚未招募
不适用
The response of intravitreal bevacizumab in the treatment of intraocular neovascularizatioOcular neovascularizationJPRN-UMIN000009389Osaka University Hospital80